Parapharmacity
0445.338.678 · rovalta.com · 22/09/2026
NORMAL SITUATION
Parapharmacity
Financial year 2025 · closed on 31/12/2025
Net result
-11,7 k €
-163.4% YoY
Gross margin
20,9 k €
-95.3% YoY
Equity
-176,5 k €
-7.1% YoY
Workforce
1,1 ETP
-84.5% YoY
Company — Normal situation.
Strike-off: 25 juin 2026
Overview
What does Parapharmacity do?
Parapharmacity is a Private limited company incorporated in 1991. It employs on average 1,1 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0445.338.678
Incorporation
07/10/1991
Legal form
Private limited company
Contributed capital
18 592,01 €
Latest accounts
31/12/2025
Average workforce
1,1 ETP
Joint committees (3)
- 11600
- 20700
- 313
Signals
Healthy social debts
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 18 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||
| Gross margin | 20,9 k € | -95.3% | 449,7 k € | -25.9% | 607,2 k € | +45.5% | 417,5 k € | -22.7% | 540 k € | +10558% | -5,2 k € | -124% | 21,7 k € | -53.9% | 47 k € | -10.4% | 52,5 k € | +19.2% | 44 k € | -34.2% | 67 k € | +42.0% | 47,1 k € | -11.6% | 53,3 k € | +2.0% | 52,3 k € | +13.7% | 46 k € | -10.7% | 51,5 k € | +8.1% | 47,6 k € | +26.8% | 37,5 k € |
| EBITDA | -1,1 k € | -101% | 77,5 k € | -52.6% | 163,7 k € | +197% | -168 k € | +0.4% | -168,8 k € | -2962% | -5,5 k € | -136% | 15,3 k € | -59.0% | 37,3 k € | +52.1% | 24,5 k € | +414% | 4,8 k € | -81.8% | 26,2 k € | +221% | 8,2 k € | +1.5% | 8 k € | +52.2% | 5,3 k € | -7.5% | 5,7 k € | -62.7% | 15,3 k € | +191% | 5,3 k € | -11.4% | 5,9 k € |
| Operating result | -1,1 k € | -102% | 44,2 k € | -64.2% | 123,5 k € | +188% | -139,6 k € | +57.2% | -325,8 k € | -5810% | -5,5 k € | -137% | 14,8 k € | -55.2% | 33 k € | +63.3% | 20,2 k € | +205% | -19,2 k € | -415% | 6,1 k € | +151% | -12 k € | +1.0% | -12,1 k € | +19.4% | -15,1 k € | -2.7% | -14,7 k € | -185% | -5,1 k € | +65.6% | -15 k € | -4.5% | -14,3 k € |
| Net result | -11,7 k € | -163% | 18,4 k € | -84.1% | 116,2 k € | +186% | -135,4 k € | +59.1% | -331,4 k € | -5948% | -5,5 k € | -157% | 9,6 k € | -61.2% | 24,6 k € | +64.8% | 15 k € | +176% | -19,7 k € | -2831% | -670,7 € | +95.4% | -14,6 k € | +15.8% | -17,3 k € | -6.2% | -16,3 k € | +4.7% | -17,1 k € | -106% | -8,3 k € | +47.7% | -15,9 k € | -14.7% | -13,9 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||
| Equity | -176,5 k € | -7.1% | -164,9 k € | +10.1% | -183,3 k € | +38.8% | -299,5 k € | -82.5% | -164,1 k € | -268% | 97,9 k € | -5.3% | 103,4 k € | +10.2% | 93,9 k € | +30.0% | 72,2 k € | +26.1% | 57,3 k € | -25.5% | 76,9 k € | -0.9% | 77,6 k € | -15.8% | 92,2 k € | -15.8% | 109,6 k € | -13.0% | 125,9 k € | -17.7% | 153 k € | -5.2% | 161,4 k € | -9.0% | 177,3 k € |
| Total assets | 2,8 M € | -4.0% | 2,9 M € | -10.5% | 3,2 M € | +105% | 1,6 M € | -62.8% | 4,3 M € | +3923% | 105,9 k € | +0.5% | 105,3 k € | -27.1% | 144,4 k € | +40.1% | 103,1 k € | +11.2% | 92,7 k € | -30.7% | 133,9 k € | +2.1% | 131,1 k € | -12.6% | 150 k € | -16.2% | 179 k € | -5.9% | 190,2 k € | -10.1% | 211,6 k € | +0.1% | 211,4 k € | -8.5% | 231 k € |
| Cash | 37,6 € | -98.8% | 3,3 k € | -95.6% | 75 k € | +20.3% | 62,4 k € | +55.1% | 40,2 k € | +410% | 7,9 k € | -90.1% | 79,5 k € | -10.5% | 88,8 k € | +75.5% | 50,6 k € | +147% | 20,5 k € | -66.9% | 61,8 k € | +40.4% | 44 k € | +20.5% | 36,5 k € | -26.7% | 49,8 k € | +9.3% | 45,5 k € | +156% | 17,8 k € | +18.1% | 15,1 k € | +15.6% | 13 k € |
| Debts | 3 M € | -3.4% | 3,1 M € | -10.5% | 3,4 M € | +82.0% | 1,9 M € | -56.7% | 4,3 M € | +54844% | 7,9 k € | +340% | 1,8 k € | -96.4% | 50,5 k € | +63.8% | 30,8 k € | -12.1% | 35,1 k € | -38.4% | 56,9 k € | +6.7% | 53,3 k € | -7.7% | 57,8 k € | -13.6% | 66,9 k € | +9.1% | 61,3 k € | +11.5% | 55 k € | +16.9% | 47 k € | -5.3% | 49,7 k € |
| Other | |||||||||||||||||||||||||||||||||||
| Workforce | 1,1 ETP | -84.5% | 7,1 ETP | -26.0% | 9,6 ETP | -28.4% | 13,4 ETP | -26.8% | 18,3 ETP | – | – | – | 0,6 ETP | 0.0% | 0,6 ETP | 0.0% | 0,6 ETP | 0.0% | 0,6 ETP | -14.3% | 0,7 ETP | -12.5% | 0,8 ETP | -11.1% | 0,9 ETP | 0.0% | 0,9 ETP | -10.0% | 1,0 ETP | 0.0% | 1,0 ETP | ||||
Governance
Board of directors
Seen on filing of 31/12/2025 · 1 active · 7 ended
Active mandates
Active
Ended mandates
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/06/2026 | 01/07/2025 | 16/07/2024 | 31/08/2023 | 30/03/2023 | 28/03/2022 |
| General meeting | 29/06/2026 | 27/06/2025 | 12/07/2024 | 30/08/2023 | 30/03/2023 | 28/03/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
20 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 29/06/2026 | 30/06/2026 | French | |
| Abridged model | 31/12/2024 | 27/06/2025 | 01/07/2025 | French | |
| Abridged model | 31/12/2023 | 12/07/2024 | 16/07/2024 | French | |
| Abridged model | 31/12/2022 | 30/08/2023 | 31/08/2023 | French | |
| Abridged model | 31/12/2021 | 30/03/2023 | 30/03/2023 | French | |
| Abridged model | 31/12/2020 | 28/03/2022 | 28/03/2022 | French | |
| Abridged model | 31/12/2019 | 18/12/2020 | 18/12/2020 | French | |
| Abridged model | 31/12/2018 | 28/06/2019 | 18/07/2019 | French | |
| Abridged model | 31/12/2017 | 29/06/2018 | 12/07/2018 | French | |
| Micro model | 31/12/2016 | 09/05/2017 | 23/06/2017 | French | |
| Abridged model | 31/12/2015 | 10/05/2016 | 20/07/2016 | French | |
| Abridged model | 31/12/2014 | 12/05/2015 | 14/07/2015 | French | |
| Abridged model | 31/12/2013 | 13/05/2014 | 16/06/2014 | French | |
| Abridged model | 31/12/2012 | 14/05/2013 | 26/07/2013 | French | |
| Abridged model | 31/12/2011 | 08/05/2012 | 05/07/2012 | French | |
| Abridged model | 31/12/2010 | 10/05/2011 | 25/05/2011 | French | |
| Abridged model | 31/12/2009 | 11/05/2010 | 23/08/2010 | French | |
| Abridged model | 31/12/2008 | 12/05/2009 | 24/08/2009 | French | |
| Abridged model | 31/12/2007 | 13/05/2008 | 28/08/2008 | French | |
| Abridged model | 31/12/2006 | 08/05/2007 | 29/08/2007 | French |
Valuation
Estimate
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 1 active · 7 ended
Active mandates
Active
Ended mandates
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Dissolution02/07/2026RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...) - DEMISSIONS, NOMINATIONS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring07/05/2026RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Mandates03/09/2025DEMISSIONS, NOMINATIONS
- Mandates06/02/2023DEMISSIONS, NOMINATIONS
- Mandates30/06/2021DEMISSIONS, NOMINATIONS
- Mandates23/03/2021STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DENOMINATION - OBJET - DEMISSIONS, NOMINATIONS
- Mandates07/02/2020DEMISSIONS, NOMINATIONS
- Other29/11/2018STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-11,7 k €↓
- 2024Annual accounts 202418,4 k €↓
- 2023Annual accounts 2023116,2 k €↑
- 2022Annual accounts 2022-135,4 k €↑
- 2021Annual accounts 2021-331,4 k €↓
- 2020Name changeParapharmacity
- 2018Annual accounts 2018-5,5 k €↓
- 2017Annual accounts 20179,6 k €↓
- 2016Annual accounts 201624,6 k €↑
- 2015Annual accounts 201515 k €↑
- 2014Annual accounts 2014-19,7 k €↓
- 2013Annual accounts 2013-670,7 €↑
- 2012Annual accounts 2012-14,6 k €↑
- 2011Annual accounts 2011-17,3 k €↓
- 2010Annual accounts 2010-16,3 k €↑
- 2009Annual accounts 2009-17,1 k €↓
- 2008Annual accounts 2008-8,3 k €↑
- 2007Annual accounts 2007-15,9 k €↓
- 2006Annual accounts 2006-13,9 k €
- 2006Name changePHARMACIE DU DOMAINE
- 07/10/1991IncorporationPrivate limited company